Skip to main content

MD Anderson to Use Sequenom Systems for Epigenomic and Genotyping Research

NEW YORK, Feb. 6 (GenomeWeb News) - The MD Anderson Kleberg Center for Molecular Markers at the University of Texas has purchased Sequenom's MassArray genetic analysis system and iPlex assay, Sequenom said today.

 

The technology will be used for the center's molecular marker research and individualized cancer case initiatives, according to a statement. Researchers at the center will use the systems to identify individuals at high risk for developing specific types of cancer, develop screeing approaches for early diagnosis of cancer, and "tailor therapy to the genetic make-up of each patient."

 

Financial details were not provided.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.